Bona Dea Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 13-12-2024
- Paid Up Capital ₹ 0.10 M
as on 13-12-2024
- Company Age 10 Year, 10 Months
- Last Filing with ROC 31 Mar 2022
- Revenue -70.15%
(FY 2022)
- Profit -275.29%
(FY 2022)
- Ebitda 44.90%
(FY 2022)
- Net Worth -101.40%
(FY 2022)
- Total Assets -4.15%
(FY 2022)
About Bona Dea Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sanjeev Yadav and Gajendra Yadav serve as directors at the Company.
- CIN/LLPIN
U85100UP2014PTC063029
- Company No.
063029
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Feb 2014
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Agra, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Bona Dea Life Sciences Private Limited offer?
Bona Dea Life Sciences Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Nutraceuticals & Dietary Supplements, Protein Powder, Juices, Soups & Soft Drinks, Beverages Mixes.
Who are the key members and board of directors at Bona Dea Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gajendra Yadav  | Director | 28-Feb-2014 | Current |
| Sanjeev Yadav | Director | 28-Feb-2014 | Current |
Financial Performance of Bona Dea Life Sciences.
Bona Dea Life Sciences Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 70.15% decrease. The company also saw a substantial fall in profitability, with a 275.29% decrease in profit. The company's net worth observed a substantial decline by a decrease of 101.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bona Dea Life Sciences?
In 2020, Bona Dea Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bona Dea Life Sciences?
Unlock and access historical data on people associated with Bona Dea Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bona Dea Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bona Dea Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
